Advanced search

Instruments

Name		Stock exchange	Average volume	Price	Type
CHARLES SCHWAB	SCHW.PRJ	Nyse +1 Other	35,632	20.01 USD	Stock
CHARLES SCHWAB	SWG0	Deutsche Boerse AG	-	18.2 EUR
CHARLES SCHWAB	SCHW.PRD	Nyse	32,828	24.89 USD	Stock
CHARLES SCHWAB	SCHW	Nyse +9 Other	6,711,723	75.88 USD	Stock
CHARLES SCHWAB	SWG	Deutsche Boerse AG	252	69.91 EUR
CHARLES SCHWAB	0L3I	London S.E.	1,917	75.8 USD
CHARLES SCHWAB CORPORATION (THE)	0L3I	CINNOBER BOAT	-	75.88 USD
CHARLES SCHWAB	SWG	Börse Stuttgart	-	69.91 EUR
THE CHARLES SCHWAB CORPORATION	SCHW	Wiener Boerse	-	70.8 EUR
THE CHARLES SCHWAB CORPORATION	SCHW *	Mexican S.E.	112	1,276 MXN
CHARLES SCHWAB	SWG	BOERSE MUENCHEN	108	70.45 EUR
CHARLES SCHWAB	SWG	Frankfurt	0	70.5 EUR
THE CHARLES SCHWAB CORPORATION		Berne S.E.	-	65.01 CHF
CHARLES SCHWAB	SCHW34	Sao Paulo	2,598	48.95 BRL	Stock
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	CRL	Nyse +6 Other	521,532	224.8 USD	Stock
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	RV6	Deutsche Boerse AG	-	212.9 EUR
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	RV6	Börse Stuttgart	-	213.5 EUR
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	RV6	BOERSE MUENCHEN	-	210.8 EUR
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	RV6	Frankfurt	-	208.9 EUR
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	CRL *	Mexican S.E.	1,250	4,049 MXN
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	RV6	Berne S.E.	-	- CHF
CHARLES & COLVARD, LTD.	CTHR	Nasdaq +1 Other	132,567	0.2932 USD	Stock
CHARLES & COLVARD, LTD.	CDR	Deutsche Boerse AG	-	0.224 EUR
MAC CHARLES (INDIA) LIMITED	MCCHRLS-B	Bombay S.E.	302	442.7 INR	Stock
CHARLES SCHWAB		Deutsche Boerse AG	-	94.59 %	Obligation
CHARLES SCHWAB		Börse Stuttgart	-	93.11 %	Obligation
CHARLES SCHWAB		Deutsche Boerse AG	-	89.64 %	Obligation

See all

News (434)

Transcript : Starbucks Corporation, Q2 2024 Earnings Call, Apr 30, 2024	01/05
Transcript : Personalis, Inc., Q4 2023 Earnings Call, Feb 28, 2024	29/02
Oxurion Avoids Bankruptcy, Announces Board and Management Changes and Enters into Binding Letter of Intent with its Main Creditor Atlas	29/12	AQ
Oxurion Avoids Bankruptcy, Announces Board and Management Changes and Enters into Binding Letter of Intent with its Main Creditor Atlas	29/12	GL
Transcript : AltaGas Ltd. - Analyst/Investor Day	05/12
Transcript : Personalis, Inc., Q3 2023 Earnings Call, Nov 07, 2023	08/11
Transcript : Starbucks Corporation - Special Call	03/11
United States Steel : Steel, Paper and Forestry, Rubber, Manufacturing, Energy, Allied Industrial and Service Workers International Union - Form 8-K	17/23/17	PU
Transcript : Glaukos Corporation, Q2 2023 Earnings Call, Aug 02, 2023	03/23/03
LivaNova Announces 150th Bipolar Depression Patient Randomized in RECOVER Clinical Study	13/23/13	BU
Orezone Gold : Voting Instruction Form	05/23/05	PU
Transcript : LivaNova PLC, Q1 2023 Earnings Call, May 03, 2023	03/23/03
Starbucks : Transcript	07/23/07	PU
Transcript : Starbucks Corporation, Q1 2023 Earnings Call, Feb 02, 2023	03/23/03
Exxon disputed climate findings for years. Its scientists knew better.	16/23/16	AQ
Pfizer : Scientific Posters(	13/22/13	PU
Westrock Coffee Hosts Groundbreaking Ceremony to Begin Refurbishments on New Facility in Conway	10/22/10	BU
Westrock Coffee Hosts Opens New Facility in Conway	10/22/10	CI
Transcript : American Well Corporation, Q3 2022 Earnings Call, Nov 07, 2022	08/22/08
Transcript : SI-BONE, Inc., Q3 2022 Earnings Call, Nov 07, 2022	08/22/08
Transcript : Starbucks Corporation, Q4 2022 Earnings Call, Nov 03, 2022	04/22/04
FOX News Media to Present Live Coverage and Special Programming Surrounding the 2022 Midterm Elections	27/22/27	BU
EXp Commercial To Host Career-focused Symposium for Real Estate Professionals Interested in Selling Commercial Properties	20/22/20	GL
EXp Commercial To Host Career-focused Symposium for Real Estate Professionals Interested in Selling Commercial Properties	20/22/20	AQ
Compagnie Plastic Omnium SE completed the acquisition of Varroc Lighting Systems, Inc. from VarrocCorp Holding B.V. for €520 million	06/22/06	CI
BIOHAVEN PHARMACEUTICAL HOLDING CO LTD. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	04/22/04	AQ
Biohaven Pharmaceutical Holding Company Announces Management Changes	04/22/04	CI
Pfizer Inc. completed the acquisition of the remaining 97.1% stake in Biohaven Pharmaceutical Holding Company Ltd. from BlackRock, Inc. and others.	03/22/03	CI
Keystone Law : ‘Outstanding’ Keystone Law commended for its ‘second to none service and high level of expertise’ in The Legal 500 2023	29/22/29	PU
Transcript : Starbucks Corporation - Analyst/Investor Day	14/22/14
Life & Banc Split : Proxy Voting Record (July 1, 2021 to June 30, 2022)	29/22/29	PU
Riverview Acquisition : Delisting/Failure to Satisfy Listing Rule/Transfer of Listing - Form 8-K	15/22/15	PU
RIVERVIEW ACQUISITION CORP. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events (form 8-K)	15/22/15	AQ
Transcript : Targa Resources Corp., Q2 2022 Earnings Call, Aug 04, 2022	04/22/04
Transcript : Energy Transfer LP, Q2 2022 Earnings Call, Aug 03, 2022	04/22/04
Transcript : Starbucks Corporation, Q3 2022 Earnings Call, Aug 02, 2022	03/22/03
Anywhere Real Estate : ERA® REAL ESTATE ANNOUNCES TOP REGIONAL SALES ASSOCIATES, BROKERS AND TEAMS FOR Q2 2022	22/22/22	PU
Transcript : Starbucks Corporation, Q2 2022 Earnings Call, May 03, 2022	04/22/04
Compagnie Plastic Omnium SE entered into an agreement to acquire Varroc Lighting Systems, Inc. from VarrocCorp Holding B.V. for €600 million.	29/22/29	CI
Transcript : Snap-on Incorporated - Shareholder/Analyst Call	28/22/28
LivaNova Announces 250th Unipolar Depression Patient Implanted in RECOVER Clinical Study	14/22/14	BU
Whiting Petroleum : Reports Fourth Quarter and Full Year 2021 Results and Oil and Gas Reserves - Form 8-K	24/22/24	PU
Whiting Petroleum Reports Fourth Quarter and Full Year 2021 Results and Oil and Gas Reserves	24/22/24	BU
The Southern Devall Group Announces Kenny Devall as President and Chief Executive Officer	09/22/09	BU
Transcript : Starbucks Corporation, Q1 2022 Earnings Call, Feb 01, 2022	02/22/02

1234NextSee all

Companies (44)

CHARLES SCHWAB 138 B $

The Charles Schwab Corporation specializes in brokerage and banking services. Net sales break down by activity as follows: - brokerage and banking services to individual investors (73.6%); - investment services to institutional investors (26.4%). Beside ...

CHARLES SCHWAB 138 B $

ENERGY TRANSFER LP 54 659 M $

Energy Transfer LP owns and operates a diversified portfolios of energy assets in the United States. The Company is engaged in natural gas operations such as natural gas midstream and intrastate transportation and storage, and interstate natural gas trans ...

ENERGY TRANSFER LP 54 659 M $

GAMING AND LEISURE PROPERTIES, INC. 12 003 M $

Gaming and Leisure Properties, Inc. is a self-administered and self-managed Pennsylvania real estate investment trust. The Company's primary business consists of acquiring, financing, and owning real estate property to be leased to gaming operators in tri ...

AÉROPORTS DE PARIS 13 410 M $

Aéroports de Paris develops and manages airports, including Paris-Charles de Gaulle, Paris-Orly and Paris-Le Bourget. In 2023, the Group handled c. 99.7 million passengers at Paris-CDG and Paris-Orly, and c. 326.7 million passengers abroad. Boasting an ex ...

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 11 815 M $

Charles River Laboratories International, Inc. specializes in the development of products and services in the field of research and non-clinical drug development for pharmaceutical companies, government agencies and academic institutions. Net sales break ...

1234Next

Insiders

Charles Conway

Dr. Charles Conway is a Chief Scientific Officer at Biohaven Pharmaceutical Holding Co. Ltd. Dr. Conway was previously employed as an Associate Director-Biology Analytics by Bristol Myers Squibb Co. He received his undergraduate degree from the University of Central Missouri, a graduate degree from the University of California San Diego and a doctorate degree from the University of California, Santa Barbara.

William E.
Conway is the founder of The Entrepreneurs EDGE, Inc. (founded in 2005) and Fairmount Santrol, Inc. (founded in 1978).
At Fairmount Santrol, he held the title of Director.
Currently, he holds the position of Director at Cleveland Botanical Garden, The Holden Arboretum, University School, Holden Forests & Gardens, and General Partner at Austin Capital Corp.
He is also a Trustee-Emeritus at The Cleveland Clinic Foundation.
In the past, he held the position of Chairman & Chief Executive Officer at Best Sand Corp.
from 1978 to 1984, and Chairman at Bison Merger Sub I LLC from 1996 to 2010.
He also held the position of Chairman at Southern Mill Creek Products of Ohio, Inc. and Independent Director at Covia Holdings LLC.
Mr. Conway received his undergraduate degree from Yale University.

G. Michael Conway

No results for this search